Article Sidebar

PDF
Date Published: 21/06/2022
Abstract Views: 170
Views PDF: 193
DOI: https://doi.org/10.51298/vmj.v514i2.2639
Issue
Vol. 514 No. 2 (2022)
Section
Các bài báo
How to Cite
Hồng Quang, L. ., & Văn Đức, N. . (2022). RESULTS OF TREATMENT DUCTAL CARCINOMA IN SITU OF BREAST CANCER AT K HOSPITAL. Vietnam Medical Journal, 514(2). https://doi.org/10.51298/vmj.v514i2.2639

RESULTS OF TREATMENT DUCTAL CARCINOMA IN SITU OF BREAST CANCER AT K HOSPITAL

Lê Hồng Quang1,, Nguyễn Văn Đức1
1 K Hospital

Main Article Content

Abstract

Objectives: To evaluate results of treatment ductal carcinoma in situ of breast cancer at  K hospital. Patients and methods: Retrospectivedescription of 78 patients with ductalcarcinoma in situ of breast cancer operatedat the Department of Breast Surgery - K Hospitalfrom January 2014 to October 2017. Results: The most common tumor location was the upper outer quadrant of the breast with 43.6%. Tumour size ≤25mm accounts for 83.3%. Intermediate-grade DCIS accounted for 52.6%; the percentage of estrogen receptor-positive was 55.1%. The mastectomy and breast-conservingsurgery rateswere 83.3% and 16.7%, respectively. Complications were found in 10.2%. The proportion of patients receiving endocrine therapy was 55.1%, and adjuvant radiation therapy was 15.4%. No recurrence and metastasis. Conclusion: Treatment of ductal carcinoma in situ of breast cancer including surgery, radiotherapy, and endocrine therapy provides good results, low surgical complications, and requires long-term follow-up to evaluate recurrence and metastasis.

Article Details

Keywords

breast cancer, ductal carcinoma in situ

References

1. Sung H., Ferlay J., Siegel R.L., et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 71(3), 209–249.
2. Kerlikowske K. (2010). Epidemiology of Ductal Carcinoma In Situ. J Natl Cancer Inst Monogr, 2010(41), 139–141.
3. Li C.I., Daling J.R., and Malone K.E. (2005). Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev, 14(4), 1008–1011.
4. Rummel S., Hueman M.T., Costantino N., et al. (2015). Tumour location within the breast: Does tumour site have prognostic ability?. Ecancermedicalscience, 9, 552.
5. Cheng L., Al-Kaisi N.K., Gordon N.H., et al. (1997). Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease. J Natl Cancer Inst, 89(18), 1356–1360.
6. Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24 | Journal of Clinical Oncology. , accessed: 03/20/2022.
7. Vargas C., Kestin L., Go N., et al. (2005). Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys, 63(5), 1514–1521.
8. Wapnir I.L., Dignam J.J., Fisher B., et al. (2011). Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS. J Natl Cancer Inst, 103(6), 478–488.
9. Narod S.A., Iqbal J., Giannakeas V., et al. (2015). Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ. JAMA Oncol, 1(7), 888–896.